Blis Technologies Limited — Board/Management Information 2021

Oct 21, 2021

==> picture [455 x 62] intentionally omitted <==

22 October 2021

Board of directors appointment

Blis Technologies advises the appointment of Aimee McCammon as a Director of the Company with effect from 21 October 2021.

Ms McCammon brings to the Board extensive marketing and governance experience. Aimee is currently CEO at Augusto Group, an independently owned hybrid creative and production company. Current governance roles include being an independent director at Flick Electric and on the Advisory Board for Pic’s Peanut Butter.

The Board has determined that Ms McCammon is an independent Director. Ms McCammon will formally offer herself for election as a Director at the next shareholders meeting in July 2022.

Ends

For further information, please contact:

Brian Watson CEO +64 27 705 9133

About Blis Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.

Website: www.unconditionalskin.com

Instagram: @unconditionalskin #BLISQ24 #USC Facebook: @unconditionalskin